Stimcell Energetics (STME) Other financing activities (2019 - 2020)
Stimcell Energetics (STME) posted quarterly Other financing activities of $124243.0 for Q3 2020, up 133.21% quarter-over-quarter from -$374148.0 in Q1 2020.
Stimcell Energetics (STME) Other financing activities (2019 - 2020) Analysis & Trends
Stimcell Energetics' Other financing activities history runs 2 years deep, the most recent figure standing at $124243.0 for Q3 2020.
- In Q3 2020, Other financing activities changed N/A year-over-year to $124243.0; the TTM figure through May 2021 stood at $124243.0 (changed N/A YoY), while the FY2021 annual figure was $124243.0, changed N/A from the prior year.
- Other financing activities for Q3 2020 stood at $124243.0, up from -$374148.0 in the prior quarter.
- The five-year high for Other financing activities was $374148.0 in Q4 2019, with the low at -$374148.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Stimcell Energetics | 4.65 Mn | 4.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Aug 31, 2020 | 124,243.00 |
| Aug 31, 2020 | 124,243.00 |
| Feb 29, 2020 | -374,148.00 |
| Feb 29, 2020 | -374,148.00 |
| Nov 30, 2019 | 374,148.00 |
| Nov 30, 2019 | 374,148.00 |